Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyo...
+1 801-676-9695
Salt Lake City
Clene Nanomedicine’s CEO is Rob Etherington
Clene Nanomedicine’s CFO is Morgan Brown
Clene Nanomedicine’s HQ is located at Salt Lake City
Clene Nanomedicine’s phone number is +1 801-676-9695
Clene Nanomedicine’s official website is clene.com
Clene Nanomedicine’s revenue is $5M - $20M
Clene Nanomedicine has 51 - 200 employees
Clene Nanomedicine is in the industry of: Pharmaceuticals